Impact of COVID-19 on cancer care pathways in a comprehensive cancer center in northern Italy.
COVID-19
cancer care
care pathway
pandemic management
quality management
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
03
2023
accepted:
18
05
2023
medline:
20
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
The COVID-19 pandemic burdened health care systems worldwide. Health services were reorganized with the dual purpose of ensuring the most adequate continuity of care and, simultaneously, the safety of patients and health professionals. The provision of care to patients within cancer care pathways (cCPs) was not touched by such reorganization. We investigated whether the quality of care provided by a local comprehensive cancer center has been maintained using cCP indicators. A retrospective single-cancer center study was conducted on eleven cCPs from 2019 to 2021 by comparing three timeliness indicators, five care indicators and three outcome indicators yearly calculated on incident cases. Comparisons of indicators between 2019 and 2020, and 2019 and 2021, were performed to assess the performance of cCP function during the pandemic. Indicators displayed heterogeneous significant changes attributed to all cCPs over the study period, affecting eight (72%), seven (63%) and ten (91%) out of eleven cCPs in the comparison between 2019 and 2020, 2020 and 2021, and 2019 and 2021, respectively. The most relevant changes were attributed to a negative increase in time-to-treatment surgery-related indicators and to a positive increase in the number of cases discussed by cCP team members. No variations were found attributed to outcome indicators. Significant changes did not account for clinical relevance once discussed by cCP managers and team members. Our experience demonstrated that the CP model constitutes an appropriate tool for providing high levels of quality care, even in the most critical health situations.
Identifiants
pubmed: 37333533
doi: 10.3389/fpubh.2023.1187912
pmc: PMC10275360
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1187912Informations de copyright
Copyright © 2023 Cigarini, Daolio, Caviola, Pellegri, Cavuto, Guberti, Mazzini and Cerullo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Am J Manag Care. 2013 May 01;19(5):e175-84
pubmed: 23781916
BMC Fam Pract. 2020 Oct 15;21(1):209
pubmed: 33059587
JMIR Res Protoc. 2020 Nov 19;9(11):e20571
pubmed: 33211017
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354
pubmed: 36923110
Front Oncol. 2023 Mar 13;13:1107384
pubmed: 36994197
Am J Clin Pathol. 2021 Mar 15;155(4):615-616
pubmed: 33382874
Elife. 2023 Apr 04;12:
pubmed: 37014058
Cancers (Basel). 2020 Oct 12;12(10):
pubmed: 33053782
JAMA Oncol. 2020 Dec 1;6(12):1881-1889
pubmed: 33119036
Front Oncol. 2021 Jun 28;11:669786
pubmed: 34262861
Front Oncol. 2021 Aug 16;11:693002
pubmed: 34485128
ESMO Open. 2020 Mar;5(2):
pubmed: 32229501
Neurosurg Focus. 2020 Dec;49(6):E10
pubmed: 33260137
Front Public Health. 2022 Apr 29;10:808873
pubmed: 35570909
Acta Reumatol Port. 2020 Oct-Dec;45(4):295-297
pubmed: 33420767
Cancers (Basel). 2023 Apr 26;15(9):
pubmed: 37173952
J Patient Rep Outcomes. 2021 Oct 14;5(1):106
pubmed: 34648095
BJU Int. 2021 Sep;128(3):271-279
pubmed: 34028162
Pract Neurol (Fort Wash Pa). 2019 Jul-Aug;18:46-49
pubmed: 33746637
Soc Sci Med. 2021 Oct;286:113885
pubmed: 34272101
JAMA. 2020 Dec 22;324(24):2483-2484
pubmed: 33351050
Healthcare (Basel). 2023 Jan 13;11(2):
pubmed: 36673615
BMC Med Educ. 2022 Jun 27;22(1):502
pubmed: 35761247
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMC Health Serv Res. 2022 Jun 27;22(1):829
pubmed: 35761282
Lancet Oncol. 2021 Nov;22(11):1507-1517
pubmed: 34624250
JCO Glob Oncol. 2021 Feb;7:162-172
pubmed: 33529077
Int J Integr Care. 2022 Aug 16;22(3):9
pubmed: 36060829
Int J Integr Care. 2022 Sep 30;22(3):23
pubmed: 36248070
Heliyon. 2022 Dec 05;8(12):e12091
pubmed: 36483302
Ann Ist Super Sanita. 2022 Jan-Mar;58(1):16-24
pubmed: 35324470
J Cancer Res Clin Oncol. 2016 Feb;142(2):481-7
pubmed: 26498774
Eur J Epidemiol. 2023 Jan;38(1):31-38
pubmed: 36593334
Clin Otolaryngol. 2017 Apr;42(2):322-329
pubmed: 27537106
ESMO Open. 2020 Aug;5(4):
pubmed: 32847836
Cancer Med. 2022 Dec;11(24):4865-4879
pubmed: 35593199
Int J Integr Care. 2020 Oct 19;20(4):4
pubmed: 33132789
Int J Technol Assess Health Care. 2018 Jan;34(1):3-9
pubmed: 29405098
J Cancer Policy. 2022 Mar;31:100316
pubmed: 35559868
Breast Cancer Res Treat. 2022 Feb;191(3):665-675
pubmed: 34988767
Prof Nurse. 2003 Aug;18(12):694-7
pubmed: 12955942
Int J Integr Care. 2019 Sep 26;19(3):19
pubmed: 31592248